According to the NFL transaction wire, the Patriots have signed defensive tackle Armond Armstead, a 6-foot-5-inch, 298-pound Southern Cal product, to a futures contract.
Armstead spent the 2012 season with the Toronto Argonauts of the Canadian Football League, helping the team win the Grey Cup championship, and was named a league All-Star.
But there is an interesting back story that led to him ending up in Canada:
While at USC, where he played from 2008-10, Armstead says he was improperly given injections of Toradol, a non-steroidal anti-inflammatory, and those injections led to him suffering a heart attack in March 2011.
He says he was not informed when he was given the injections what the medication was or that there was a risk of heart attack or stroke when taking it.
Armstead was briefly hospitalized, and USC would not clear him medically to play in 2011. He thought about transferring to another college but opted instead to turn pro. He was not taken in the NFL draft or signed as a free agent in 2012, likely because of concerns over his health history. Armstead went to the CFL instead.
Last August, Armstead brought suit against USC, University Park Health Center, USC team physician James Tibone, and an unnamed pharmaceutical company.